News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Botanic Schedules Conference Call to Discuss FY 2010 Fourth Quarter and Full Year Results



1/20/2011 9:11:12 AM

HARBIN, China, Jan. 20, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), today announced that it will host a conference call at 9:00 a.m. Eastern Time on Tuesday, January 25, 2011, to discuss financial results for the fourth quarter of fiscal year 2010 and for the fiscal year ended October 31, 2010.

Joining Mr. Shaoming Li, China Botanic's chairman and CEO, will be Mr. Guangtao Li, the Company's vice president andMr. David Dong, the Company's CFO.

To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-394-2209. International callers should dial +1-706-758-1481. The conference ID number for the call is 38464897.

If you are unable to participate in the call at this time, a replay will be available on Tuesday, January 25, 2011 at 10:00 am Eastern Time, through Tuesday, February 8, 2011. To access the replay, dial 800-642-1687. International callers should dial +1-706-645-9291. The conference ID number for the replay is 38464897.

ABOUT CHINA BOTANIC PHARMACEUTICAL INC.

China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China.

Company Contact:

CCG Investor Relations:

China Botanic Pharmaceutical Inc.

Mr. Mark Collinson, Partner

Ms. Portia Tan, IR Contact

Phone: +1-310-954-1343 (Los Angeles)

Tel: 86-451-8260-2162

Email: mark.collinson@ccgir.com

Email: ir@renhuang.com

Website: www.ccgirasia.com




Mr. Crocker Coulson, President


Phone: +1-646-213-1915 (New York)


Email: crocker.coulson@ccgir.com



SOURCE China Botanic Pharmaceutical Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES